![](https://webarchive.library.unt.edu/eot2008/20090513215138im_/http://www.cancer.gov/images/spacer.gif) |
|
Symptom Prevalence Among Patients Treated for Hypercalcemia
of Malignancy Stratified by Corrected Serum Total Calcium
Concentrations at Presentation*
Symptoms
|
Prevalence (%) by Serum Calcium
Concentration
|
*Adapted from Ralston et al.[3]
|
|
<3.5 mmol/L
|
≥3.5 mmol/L
|
Central nervous system symptoms |
41 |
80 |
Constipation |
21 |
25 |
Malaise-fatigue |
65 |
50 |
Anorexia |
47 |
59 |
Nausea and/or vomiting |
22 |
30 |
Polyuria and/or polydipsia |
34 |
35 |
Pain |
51 |
35 |
References
-
Ralston SH, Gallacher SJ, Patel U, et al.: Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients. Ann Intern Med 112 (7): 499-504, 1990.
[PUBMED Abstract]
|
|
![](https://webarchive.library.unt.edu/eot2008/20090513215138im_/http://www.cancer.gov/images/spacer.gif) |